Anonymous
Guest
Anonymous
Guest
well you had to know that the dpp-4 window was narrow and is now closing fast. soon it will be like arb's and statins - every company will have one. then the micro increases will go to the best marketers (diovan) most agressive w/mco's (benicar) or most effective (lipitor). Which is all to say - history is not in merck's corner.
Januvia's Lipitor is coming. Then job security is all but trashed.